Skip to main content
LAVA Therapeutics N.V. (LVTX)
NASDAQ: LVTX · Real-Time Price · USD
1.215
-0.025 (-2.02%)
May 6, 2025, 12:15 PM EDT - Market open

Revenue by Product

Fiscal year is January - December.
Fiscal Year
 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
 Dec '23 Dec '22 Dec '21 Dec '20
Novel Bispecific Antibodies
7.32M
Log In
Log In
Log In
Novel Bispecific Antibodies Growth
-64.09%
Log In
Log In
Log In

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
 Dec '23 Dec '22 Dec '21 Dec '20
Netherlands
7.32M
Log In
Log In
Log In
Netherlands Growth
-64.09%
Log In
Log In
Log In